16 results
Here is a quick guide on the common direct-acting antivirals (DAAs) for chronic hepatitis C virus
#DAAs #Antivirals ... #table #treatment ... infectiousdisease #hepatology ... HepC #HepatitisC #Management ... #Pharmacology
Treatment Algorithm for First Time Pulmonary Embolism
 • Provoked
 • Unprovoked
 • Active Malignancy

By Carlin Rooke,
Treatment Algorithm ... for First Time Pulmonary ... #PE #Pulmonary # ... #Algorithm #management ... #hematology #VTE
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
#management #algorithm ... #pharmacology # ... treatment #medications ... #table #pharmacotherapy ... decisionaid #cardiology #hematology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
Treatment algorithm ... algorithm for symptomatic ... of at least 5 days ... Anticoagulation #Management ... #Hematology #Oncology
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... for the treatment ... thrombosis; PE = pulmonary ... Anticoagulation #Management ... #Hematology #Oncology
“Step by Step” – the new kid on the block – aims to risk stratify this
investigations and treatments ... appearing - Aged >21 days ... Procalcitonin <0.5 ng/mL ... #Diagnosis #Management ... #Pediatrics #Peds
Blood Product Components, Contents, Volume and Shelf Life

Whole blood (autologous or directed donations) - RBC and
decreased after 2 days ... with about 25 mL ... plasma and 100 mL ... Contents #Volume #Hematology ... #Management #Table
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
Triggers: ATRA treatment ... Imaging: CXR- pulmonary ... Renal Failure Treatment ... APML #diagnosis #management ... #hematology #oncology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
mucoadhesive buccal tablet ... chew, or crush tablet ... suspension 4–6 mL ... #management #opportunistic ... infections #HIVAIDS #pharmacology
Algorithm regarding the diagnosis and treatment of Hereditary Hemochromatosis HH. 

Step 1: In the patient with
Algorithm regarding ... diagnosis and treatment ... including liver and hematologic ... #diagnosis #management ... #hepatology #gastroenterology